Early vs. Late-Stage Periarticular Injection During Unicompartmental Knee Arthroplasty .
Early Stage Versus Late Stage Periarticular Injection during Unicompartmental Knee Arthroplasty for Postoperative Pain Relief: A Randomized Controlled Trial
J Knee Surg. 2022 Nov;35(13):1425-1433.Eighty-four patients undergoing unicompartmental knee arthroplasty were randomized to receive a periarticular injection performed prior to joint incision (early stage; n=42) or after implantation of the prosthesis (late stage; n=42). The primary outcome of interest was pain intensity, measured on a 100-point Visual Analog Scale (VAS). Secondary outcomes of interest included range of motion, rescue analgesia consumption, and in-hospital complications, measured up to 120 hours post-operation. The results of this study found early-stage injection to provide superior pain relief in the post-operative recovery room. However, no differences in pain intensity were observed between the two groups at 3-120 hours post-operation. No differences in secondary outcomes were observed between the two groups.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics